| 规格: | 98% |
| 分子量: | 488.62 |
| 包装 | 价格(元) |
| 10mg | 电议 |
| 50mg | 电议 |
Background:
Negative control for PF CBP1. Exhibits negligible activity at CBP and BRD4. Active Analog also available.
Chekler et al (2015) Transcriptional profiling of a selective CREB binding protein bromodomain inhibitor highlights therapeutic opportunities. Chem.Biol. 22 1588 PMID:26670081
m.cnreagent.com